208 related articles for article (PubMed ID: 7389217)
21. In vivo effect of clofazimine in the lysosomal enzyme level and immune complex phagocytosis of mouse peritoneal macrophages.
Sarracent J; Finlay CM
Int J Lepr Other Mycobact Dis; 1984 Jun; 52(2):154-8. PubMed ID: 6539307
[TBL] [Abstract][Full Text] [Related]
22. Hydrolytic enzyme of the alveolar macrophage in diffuse pulmonary interstitial disease.
Pérez-Arellano JL; Barrios MN; Martín T; Sánchez ML; Jiménez A; González-Buitrago JM
Respir Med; 1996 Mar; 90(3):159-66. PubMed ID: 8736208
[TBL] [Abstract][Full Text] [Related]
23. Hypothesis: exposure to solvents may cause fibrosing alveolitis.
Billings CG; Howard P
Eur Respir J; 1994 Jun; 7(6):1172-6. PubMed ID: 7925888
[TBL] [Abstract][Full Text] [Related]
24. [Effect of trypsin on the cell surface : influence on the lysosomal exocytosis of alveolar macrophages of the guinea pig].
Sablonnière B; Scharfman A; Aerts C; Roussel P
C R Seances Acad Sci III; 1981 Feb; 292(8):561-4. PubMed ID: 6784959
[TBL] [Abstract][Full Text] [Related]
25. Induction of macrophage lysosomal enzyme secretion by agents acting at the plasma membrane.
Dean RT; Hylton W; Allison AC
Exp Cell Biol; 1979; 47(6):454-62. PubMed ID: 520650
[TBL] [Abstract][Full Text] [Related]
26. Desquamative form of cryptogenic fibrosing alveolitis in a cat.
Rhind SM; Gunn-Moore DA
J Comp Pathol; 2000; 123(2-3):226-9. PubMed ID: 11032682
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of inflammatory cytokine secretion by human alveolar macrophages.
Losa García JE; Rodríguez FM; Martín de Cabo MR; García Salgado MJ; Losada JP; Villarón LG; López AJ; Arellano JL
Mediators Inflamm; 1999; 8(1):43-51. PubMed ID: 10704089
[TBL] [Abstract][Full Text] [Related]
28. C-C chemokine receptor 2 (CCR2) deficiency improves bleomycin-induced pulmonary fibrosis by attenuation of both macrophage infiltration and production of macrophage-derived matrix metalloproteinases.
Okuma T; Terasaki Y; Kaikita K; Kobayashi H; Kuziel WA; Kawasuji M; Takeya M
J Pathol; 2004 Dec; 204(5):594-604. PubMed ID: 15538737
[TBL] [Abstract][Full Text] [Related]
29. Fine structural changes in cryptogenic fibrosing alveolitis and asbestosis.
Corrin B; Dewar A; Rodriguez-Roisin R; Turner-Warwick M
J Pathol; 1985 Oct; 147(2):107-19. PubMed ID: 4067730
[TBL] [Abstract][Full Text] [Related]
30. [Antibodies against tissue antigens in idiopathic diffuse interstitial pulmonary fibrosis (cryptogenic fibrosing alveolitis) (author's transl)].
Levinský L; Jezková Z
Sb Lek; 1976 Aug; 78(8):225-9. PubMed ID: 981948
[No Abstract] [Full Text] [Related]
31. [Clinical importance of the dynamics of the cytological findings in lavage fluid in patients with biopsy-proven cryptogenic fibrosing alveolitis].
Homolka J; Bohut V; Votava V; Voslárová Z; Zatloukal P
Cas Lek Cesk; 1988 May; 127(19):589-92. PubMed ID: 3396044
[No Abstract] [Full Text] [Related]
32. Different cytokine profiles in cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: a quantitative study of open lung biopsies.
Majumdar S; Li D; Ansari T; Pantelidis P; Black CM; Gizycki M; du Bois RM; Jeffery PK
Eur Respir J; 1999 Aug; 14(2):251-7. PubMed ID: 10515397
[TBL] [Abstract][Full Text] [Related]
33. [IgG-Fc receptor activity of alveolar macrophage in patients with various diffuse pulmonary diseases].
Chihara J
Nihon Kyobu Shikkan Gakkai Zasshi; 1985 Jul; 23(7):790-8. PubMed ID: 2934570
[No Abstract] [Full Text] [Related]
34. C3b induces macrophage enzyme secretion.
Schorlemmer HU; Allison AC
Monogr Allergy; 1977; 12():115-9. PubMed ID: 917015
[No Abstract] [Full Text] [Related]
35. Evaluation of alveolitis by studies of lung biopsies.
Haslam PL
Lung; 1990; 168 Suppl():984-92. PubMed ID: 2117219
[TBL] [Abstract][Full Text] [Related]
36. Maturation-linked expression of C3b and C3b' receptors on developing human bone marrow and peripheral blood granulocytes.
Scott CS
Clin Exp Immunol; 1981 Apr; 44(1):201-10. PubMed ID: 7261476
[TBL] [Abstract][Full Text] [Related]
37. High resolution computed tomographic assessment of asbestosis and cryptogenic fibrosing alveolitis: a comparative study.
al-Jarad N; Strickland B; Pearson MC; Rubens MB; Rudd RM
Thorax; 1992 Aug; 47(8):645-50. PubMed ID: 1412123
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical localization of transforming growth factor-beta 1 in the lungs of patients with systemic sclerosis, cryptogenic fibrosing alveolitis and other lung disorders.
Corrin B; Butcher D; McAnulty BJ; Dubois RM; Black CM; Laurent GJ; Harrison NK
Histopathology; 1994 Feb; 24(2):145-50. PubMed ID: 8181807
[TBL] [Abstract][Full Text] [Related]
39. Epidemiology of cryptogenic fibrosing alveolitis in Moravia and Silesia.
Kolek V
Acta Univ Palacki Olomuc Fac Med; 1994; 137():49-50. PubMed ID: 7778506
[TBL] [Abstract][Full Text] [Related]
40. The immunological architecture of B-lymphocyte aggregates in cryptogenic fibrosing alveolitis.
Wallace WA; Howie SE; Krajewski AS; Lamb D
J Pathol; 1996 Mar; 178(3):323-9. PubMed ID: 8778339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
